Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 23, 2026
Strive (ASST) Climbs +61% Over 30 Days as Bitcoin Rebounds

Strive (ASST) Climbs +61% Over 30 Days as Bitcoin Rebounds

Key Takeaways

  • ASST shares climbed roughly 61% over the last 30 days, rising from about $18.22 on Aug. 21 to $29.35 at the Sept. 22 close.
  • The advance tracks a broad Bitcoin rebound and Strive's aggressive treasury accumulation, including roughly 3,156 BTC added during August.
  • Over the trailing three months, ASST advanced about 98%, extending a 2026 rally that pushed year-to-date gains near 99%.
  • Analysts remain constructive, with a consensus Strong Buy rating and recent price-target increases from B. Riley and TD Cowen.
  • The stock is highly volatile and trades at a premium to its Bitcoin holdings' net asset value, reflecting sensitivity to crypto prices and execution risk.

Strive's Role as a Bitcoin Treasury Company

Strive, Inc. is a Nasdaq-listed Bitcoin treasury company and asset manager co-founded by Vivek Ramaswamy. The company went public through a reverse merger with Asset Entities completed in September 2025. Strive operates a zero-debt model, financing Bitcoin purchases primarily through preferred equity and equity issuances rather than traditional borrowing. As of recent disclosures, Strive held roughly 23,156 BTC, ranking it among the largest publicly traded corporate Bitcoin holders, with a market capitalization of approximately $2.8 billion. Investors follow the stock closely because its performance is closely tied to Bitcoin's price and to the pace of the company's treasury accumulation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

ASST Stock Price Performance Over the Past Month and Quarter

Over the last 30 days, ASST advanced approximately 61%, moving from a close near $18.22 on Aug. 21 to $29.35 at the Sept. 22 close. The rally was not linear: after breaking out in mid-August, the stock climbed through early September, briefly pushing the company's market capitalization above $3 billion, before pulling back modestly from an intraday high above $31.

The trailing three-month trend is even stronger. ASST traded near $14.81 in late June and dipped to roughly $10.91 by the end of that month amid crypto-market weakness, before rebounding to $29.35 in late September—a gain of about 98% over the quarter. This recovery reflects both a broader turn in digital-asset sentiment and Strive's continued expansion of its Bitcoin treasury.

Factors Behind the Recent 30-Day Advance

The 30-day surge was driven primarily by a powerful rebound in Bitcoin and Strive's accelerated accumulation of it. The rally in crypto risk assets gained momentum in mid-August after the U.S. Treasury's announcement that it would double long-term bond repurchases, which pushed yields lower and supported speculative assets. Bitcoin rose more than 20% over the period, lifting Bitcoin-treasury equities broadly.

Strive added roughly 3,156 BTC during August, including a $143 million purchase of 1,800 BTC at an average cost near $79,431 per coin, disclosed through an 8-K filing. The accumulation lifted the company's holdings to about 23,156 BTC and cemented its position among the top five public corporate Bitcoin holders. CEO Matt Cole said in early September that finishing 2026 as the second-largest public Bitcoin holder was "not out of the realm of possibility." The company also holds roughly $700 million in warrants exercisable at a $27 strike price, giving it a potential funding source for further purchases.

Analyst activity reinforced the move. TD Cowen raised its price target to $44 from $32 with a Buy rating, and B. Riley lifted its target to $33 from $26 while maintaining a Buy rating. The consensus rating stands at Strong Buy, with an average price target near $32.

Drivers of the Quarterly Performance

The quarterly advance reflects a broader re-rating of corporate Bitcoin treasury strategies. After a late-June pullback, Strive's shares recovered as institutional Bitcoin adoption expanded and spot ETF flows supported the asset. The company's zero-debt funding model and its reported Bitcoin yield—around 40.8% as of late August—distinguished it from competitors that rely on convertible debt. Rising analyst coverage, including new Buy initiations, also contributed to the multi-month trend. The stock's year-to-date gain of roughly 99% and its climb well above its Bitcoin net asset value underscore both the scale of the rally and the heightened valuation sensitivity that comes with it.

Key Areas to Monitor Going Forward

Bitcoin's price trajectory remains the dominant driver of ASST shares, along with Strive's pace of accumulation and its ability to fund purchases without excessive dilution. Investors should monitor the company's quarterly disclosures for updated holdings and Bitcoin-yield metrics, with its next earnings report estimated for early November 2026. The potential exercise of outstanding warrants near the $27 strike price and any additional equity issuances will influence share count and valuation. Competitive positioning against larger treasury operators such as Strategy (MSTR) and the evolving regulatory environment for digital assets are also important considerations. As the stock trades at a premium to its Bitcoin net asset value, volatility tied to crypto prices and execution risk remain key factors for investors to weigh. From what I see, reviewing these elements with data tools helps clarify the risks involved.

Using Tickeron AI Tools for Analysis

In my own research process, I have found Tickeron’s AI Trading Bots helpful for examining systematic strategies across volatile names like this one. The platform offers a range of automated approaches that can align with different risk tolerances and timeframes, providing another layer of perspective when evaluating treasury plays tied to Bitcoin. It serves as a practical starting point rather than a definitive signal, which is useful when weighing accumulation pace and market sentiment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ASST

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ASST sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ASST moved above the 200-day moving average on September 04, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ASST moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ASST crossed bullishly above the 50-day moving average on August 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 70%.

Following a +7.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in 127 of 148 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 57 of 69 cases where ASST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

ASST broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ASST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.423) is normal, around the industry mean (3.373). P/E Ratio (0.000) is within average values for comparable stocks, (27.127). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.355). ASST has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.080). ASST's P/S Ratio (113.636) is very high in comparison to the industry average of (15.971).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 8.94B. The market cap for tickers in the group ranges from 57 to 165.68B. BLK holds the highest valuation in this group at 165.68B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 3%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 10%. AVAT experienced the highest price growth at 78%, while BENF experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 56%. For the same stocks of the Industry, the average monthly volume growth was 65% and the average quarterly volume growth was 38%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 31
P/E Growth Rating: 54
Price Growth Rating: 55
SMR Rating: 67
Profit Risk Rating: 79
Seasonality Score: -43 (-100 ... +100)
View a ticker or compare two or three
ASST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InvestmentManagers

Industry
N/A
Address
200 Crescent Court
Phone
+1 855 427-7360
Employees
28
Web
https://www.strive.com
Interact to see
Advertisement
The Fed kept rates at 3.5–3.75% and signaled a “higher for longer” stance, with no urgency to cut and a willingness to tighten again if inflation stalls. This backdrop tends to favor quality growth, financials, energy, industrials, and health care, while pressuring long‑duration, leveraged sectors like speculative tech, small caps, utilities, and REITs.
PICS shares fell over 20% today, reversing much of their post‑IPO bounce and dropping well below the US$19 IPO price after initially trading in the mid‑US$15–16 range. The selloff followed PicPay’s Q4 and full‑year 2025 results, which showed strong revenue growth but highlighted thin margins, intense competition and ongoing execution risk in credit underwriting and payments.
RCAT shares fell over 16% today, dropping from recent levels near US$17 toward the mid‑US$14–15 range, after trading as high as US$18.78 in the past year and more than tripling from a 52‑week low of US$4.60.
HYMC shares fell over 13% today, sliding from the mid‑US$30s toward roughly US$31, after trading between US$2.30 and US$58.73 over the past 12 months and closing near US$39 just a few sessions ago.
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.